If this is what the secret squirrel stuff some were going on about earlier in the week, it is a bit of a fizzer .... good to see the patent granted but realistically it is not like it wasn't expected ? I mean who else were they going to award the patent to for DEP® cabazitaxel ?
It's not like Sanofi could dispute it as they don't own the DEP technology and let's face it, Starpharma didn't even nominate the announcement as price sensitive for the reasons I have outlined above
I guess we will see if Sanofi are interested enough in it to sign a deal whenever the trials finish next year (or the year after knowing SPL)... we all know how DEP® Remdesivir went - JF is still waiting for Gilead to return her call IMO ?
Ann: US patent issued for DEP cabazitaxel nanoparticle, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.97M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 9.9¢ | 9.7¢ | $44.76K | 455.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 824859 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 121525 | 5 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |